Scotiabank Maintains Outperform on Gildan Activewear Inc. (GIL) Feb 2026

Scotiabank maintained an Outperform rating on Gildan Activewear Inc. (GIL) on February 03, 2026, while raising its price target to $72 from $66. The move is the core change in the latest GIL analyst rating update and signals confidence tied to recent strategic developments. Scotiabank issued the note at 10:37 AM and flagged specific deal and margin drivers behind the target raise. Investors should weigh that maintained rating alongside the new price target when assessing upside.

Key takeaways on the GIL analyst rating

Scotiabank maintained Outperform for Gildan Activewear Inc. (GIL) on Feb 03, 2026 and raised the price target to $72 from $66. This single analyst action is the day’s material coverage update for GIL and combines a steady rating with a more bullish valuation.

GIL analyst rating: price target raise and rationale

Scotiabank cited deal-related synergies and margin improvement as reasons to raise the GIL price target to $72; the firm left the underlying rating unchanged at Outperform. The formal note and headline are reported by TheFly and summarized by Investing.com TheFly report Investing.com summary.

Scotiabank’s action and historical coverage

Scotiabank has followed Gildan Activewear Inc. across recent quarters and kept a positive stance as strategic moves unfolded. The maintained Outperform is consistent with prior coverage that emphasized operational leverage and brand positioning in core apparel segments.

Market reaction and stock performance

The action coincided with a modest market move of 0.42% ($0.28) on the day of the note. With a market cap of $9,999,563,610, Gildan’s shares typically respond to target changes more than to rating maintenance, so the price target increase likely mattered more to near-term traders.

What the rating change means for investors

A maintained Outperform with a higher price target suggests analysts see upside but not a material change in risk profile. For long-term investors the update refines valuation expectations; for short-term traders the $72 target signals potential upside based on Scotiabank’s model assumptions.

Meyka context and consensus framing for GIL analyst rating

Meyka AI rates GIL with a grade of B+. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Our AI-powered market analysis places the Scotiabank note within a modestly positive consensus backdrop and recommends tracking execution on the deal assumptions. See the detailed stock page for GIL on Meyka: Gildan Activewear (GIL) on Meyka.

Final Thoughts

Scotiabank’s Feb 03, 2026 note left the rating at Outperform but raised the GIL price target to $72 from $66, a clear signal that the firm sees more upside on revised assumptions. The action is a maintenance of positive conviction rather than a directional upgrade or downgrade of conviction level. For investors the practical takeaway is that valuation expectations have shifted higher while risk assessment stayed steady. Traders may react to the new target quickly, but long-term holders should watch whether the company delivers the margin and deal synergies Scotiabank cites. Given the company’s $9,999,563,610 market cap and a modest intraday move of 0.42% ($0.28) on the announcement date, the market treated the note as incremental confirmation rather than a surprise. Meyka AI’s B+ rating for GIL reflects those same elements: relative benchmark performance, sector positioning, growth metrics, and the analyst consensus nudged higher by the price target revision. These updates are informational and not investment advice; investors should combine them with portfolio goals and risk tolerance before acting.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.